Outcomes in patients with tuberous sclerosis complex-associated treatment-refractory seizures, transitioning from placebo in core phase to everolimus during extension phase of the EXIST-3 trial


French J. A. , Lawson J. A. , Yapici Z. , Ikeda H., Polster T., Nabbout R., ...More

23rd World Congress of Neurology (WCN), Kyoto, Japan, 16 - 21 September 2017, vol.381, pp.87 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 381
  • Doi Number: 10.1016/j.jns.2017.08.293
  • City: Kyoto
  • Country: Japan
  • Page Numbers: pp.87